DB05859ExperimentalSmall molecule
PI-166 is a small organic compound with specific avidity to liver cancer cells. It has demonstrated the ability to reduce the growth of rat hepatomas, which is like human hepatomas,...
- Mechanism
- Curator reviewed
PI-166 is an anti-cancer formulation with a very high affinity for primary liver cancer (hepatoma) cells.
- Primary indication
- Investigated for use/treatment in liver cancer.Curator reviewed
- Code names
- PI-166
Which companies are running trials of PI-166, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account